Stock ACAD ACADIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions ACADIA Pharmaceuticals Inc.

Equities

ACAD

US0042251084

Market Closed - Nasdaq
Other stock markets
 01:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
17.1 USD +2.33% Intraday chart for ACADIA Pharmaceuticals Inc. +0.65% -45.38%
23/04 Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada MT
22/04 Acadia Pharmaceuticals' Rett Syndrome Treatment Granted Priority Review by Health Canada MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ACAD Stock
  4. Revisions ACADIA Pharmaceuticals Inc.